580 related articles for article (PubMed ID: 17473211)
1. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
[TBL] [Abstract][Full Text] [Related]
2. Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Luongo CL; Komarova S; Kawakami Y; Curiel DT
Biochem Biophys Res Commun; 2005 Sep; 335(1):205-14. PubMed ID: 16061208
[TBL] [Abstract][Full Text] [Related]
3. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
Takayama K; Reynolds PN; Short JJ; Kawakami Y; Adachi Y; Glasgow JN; Rots MG; Krasnykh V; Douglas JT; Curiel DT
Virology; 2003 May; 309(2):282-93. PubMed ID: 12758175
[TBL] [Abstract][Full Text] [Related]
4. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
5. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
[TBL] [Abstract][Full Text] [Related]
6. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
7. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
Stepanenko AA; Chekhonin VP
Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
[TBL] [Abstract][Full Text] [Related]
8. Dependence of adenovirus infectivity on length of the fiber shaft domain.
Shayakhmetov DM; Lieber A
J Virol; 2000 Nov; 74(22):10274-86. PubMed ID: 11044071
[TBL] [Abstract][Full Text] [Related]
9. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
[TBL] [Abstract][Full Text] [Related]
11. Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.
Breidenbach M; Rein DT; Wang M; Nettelbeck DM; Hemminki A; Ulasov I; Rivera AR; Everts M; Alvarez RD; Douglas JT; Curiel DT
Hum Gene Ther; 2004 May; 15(5):509-18. PubMed ID: 15144580
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.
Law LK; Davidson BL
J Virol; 2002 Jan; 76(2):656-61. PubMed ID: 11752156
[TBL] [Abstract][Full Text] [Related]
13. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
[TBL] [Abstract][Full Text] [Related]
14. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
[TBL] [Abstract][Full Text] [Related]
15. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
[TBL] [Abstract][Full Text] [Related]
16. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
Nakamura T; Sato K; Hamada H
J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
[TBL] [Abstract][Full Text] [Related]
17. CD46 represents a target for adenoviral gene therapy of malignant glioma.
Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
[TBL] [Abstract][Full Text] [Related]
18. Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini.
Xie J; Chiang L; Contreras J; Wu K; Garner JA; Medina-Kauwe L; Hamm-Alvarez SF
J Virol; 2006 Dec; 80(23):11833-51. PubMed ID: 16987972
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.
Kanerva A; Wang M; Bauerschmitz GJ; Lam JT; Desmond RA; Bhoola SM; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
Mol Ther; 2002 Jun; 5(6):695-704. PubMed ID: 12027553
[TBL] [Abstract][Full Text] [Related]
20. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
